DCM
RLAY icon

Driehaus Capital Management’s Relay Therapeutics RLAY Stock Holding History

Driehaus Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-616,220
Closed -$4.02M – 440
2024
Q2 		$4.02M Buy
616,220
+218,302
+55% +$1.49M 0.04% 270
2024
Q1 		$3.3M Sell
397,918
-195,084
-33% -$1.9M 0.03% 290
2023
Q4 		$6.53M Hold
593,002
– – 0.08% 258
2023
Q3 		$4.99M Hold
593,002
– – 0.06% 282
2023
Q2 		$7.45M Sell
593,002
-989,249
-63% -$12.3M 0.09% 249
2023
Q1 		$26.1M Sell
1,582,251
-36,102
-2% -$647K 0.37% 80
2022
Q4 		$24.2M Sell
1,618,353
-1,349,092
-45% -$25.8M 0.36% 88
2022
Q3 		$66.4M Sell
2,967,445
-125,281
-4% -$2.75M 1.01% 16
2022
Q2 		$51.8M Sell
3,092,726
-957,962
-24% -$20.5M 0.84% 20
2022
Q1 		$121M Buy
4,050,688
+16,332
+0.4% +$396K 1.49% 3
2021
Q4 		$124M Buy
4,034,356
+983,654
+32% +$31.1M 1.26% 5
2021
Q3 		$96.2M Buy
3,050,702
+196,662
+7% +$6.62M 1.14% 9
2021
Q2 		$104M Buy
2,854,040
+311,421
+12% +$10.3M 1.38% 6
2021
Q1 		$87.9M Buy
2,542,619
+1,446,339
+132% +$62.8M 1.3% 8
2020
Q4 		$45.6M Buy
1,096,280
+23,271
+2% +$1.05M 0.74% 28
2020
Q3 		$45.7M Buy
+1,073,009
New +$40.9M 0.94% 16

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Driehaus Capital Management's RLAY Position: Q3 2024 in Review

Driehaus Capital Management sold out of Relay Therapeutics (RLAY) in Q3 2024, closing a stake of 616,220 shares — an estimated $4.02M sold.

Driehaus Capital Management first reported a position in RLAY in Q3 2020 and held it in 16 quarters. The position peaked at $124M in Q4 2021. 195 funds tracked by Wall St. Rank hold RLAY as of Q3 2024.

  • Driehaus Capital Management reported no remaining Relay Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 616,220 Relay Therapeutics shares in Q3 2024, an estimated $4.02M.
  • Driehaus Capital Management first reported a position in Relay Therapeutics in Q3 2020 and held it in 16 quarters.
  • Driehaus Capital Management's Relay Therapeutics position peaked at $124M in Q4 2021.
  • 195 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2024.

Based on Driehaus Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.